sp-333
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2012 (NCT01705938)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- sp-333
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01983306 | Phase 2 | Nov 1, 2013 | Synergy Pharmaceuticals |
| NCT01705938 | Phase 1 | Oct 1, 2012 | Anaheim Clinical Trials, Synergy Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Synergy Pharmaceuticals | For profit | 2 | 2 | 2 | 2012 |
| Anaheim Clinical Trials | For profit | 1 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1